Strategy

Programmable Immunity | Ep. 1052

The Real Opportunity in In-Vivo CAR Therapies

Aug 9

The Last Shot Strategy | Ep. 1047

What Happens When Biotech Goes Virtual to Survive

Aug 2

Internal Innovation or Strategic Sourcing? | Ep. 1043

Rethinking Pharma's Growth Engine

Jul 26

Liquidity, Beta, and the Biotech Edge | Ep. 1038

Finding Alpha When the Herd Gets Whiplashed

Jul 19

Inflammation at the Helm | Ep. 1037

Reprogramming the Brain’s Immune Axis to Rewrite Neurodegeneration

Jul 12

When Consensus Gets Distorted | Ep. 1032

Using Consensus Distortion Index (CDI) & Options Volatility to Trade Biotech Narratives

Jul 5

From Bench to Barrier | Ep. 1028

The Next Era of IBD Drug Development Has Arrived

Jun 28

The FDA Clock Is Ticking | Ep. 1024

Bioprinted Organoids and the Therapeutic Shortcut Hiding in Plain Sight

Jun 21

R&D Success Rates in Pharma | Ep. 1018

What They Do (and Don’t) Tell You

Jun 14

Lipid Logic | Ep. 1014

The Next Era of Cardiometabolic Therapeutics

Jun 7

Breaking the Code | Ep. 1009

How Enhancers Are Rewriting the Rules of Genetics

May 31

The Energy Broker | Ep. 1006

Why the Brain Might Be the Master Switch of Ageing

May 24

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts